Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"Replication will require tens of millions of dollars that IPIX simply don't have."
"IMO, a 2-person trial showing trial showing efficacy is probably not enough to attract suitors interested in ultimately spending hundreds of millions of dollars on K-OC."

All true and thanks for providing some support for it. But the costs of cancer drug development have been known for a long time....since prior to the initial Kevetrin studies. So why did CTIX undertake a process that they should have known they could not complete?